Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine vs Acetaminophen for Pain During Head Frame Application
NCT07525219Phase 3Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suzetrigine in acute pain, sponsored by Wake Forest University Health Sciences. Started Jun 2026; status: recruiting.
02
Drugs
suzetrigine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07525219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525219.